Privigen (CSL Behring AG)
Welcome to the PulseAid listing for the Privigen drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | CSL Behring AG |
| NON-PROPRIETARY NAME: | Human Immunoglobulin G |
| SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-01-20 |
| END MARKETING DATE: | 0000-00-00 |
Privigen PLASMA DERIVATIVE Details:
| Item Description | Privigen from CSL Behring AG |
| LABELER NAME: | CSL Behring AG |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(g/50mL) |
| START MARKETING DATE: | 2009-01-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44206-436_e61a518f-4c78-41e6-86ed-2486561b2cf4 |
| PRODUCT NDC: | 44206-436 |
| APPLICATION NUMBER: | BLA125201 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers:
